NFKB1 and Blau syndrome: However, for NOD2 mutations, differential enhancement of NF-κB transcription was dependent on the site of the NOD2 mutation when evaluated in HEK293 cells (15) and the differences did not necessarily correlate with the severity of clinical symptoms in Blau syndrome.